AiCuris Anti-infective Cures AG - Projects

As innovator for antiviral and antibacterial therapies, AiCuris targets infectious diseases with high unmet medical need. With the experience of big pharma but the flexibility and scalability of a small biotech, we are driven by scientific expertise and collaborate with a wide array of academic and business partners. This enables us access to various technologies, platforms and sub-contractors – each time selected according to project needs.

Late-stage programs

Pritelivir (AIC316)
Pritelivir (AIC316)

Treating acyclovir-resistant HSV infection

Read more
AIC468 BK Virus
AIC468 BK Virus

RNA-based therapy to prevent BK viral infection in transplanted kidneys

Read more
Prevymis® / Letermovir (AIC246)
Prevymis® / Letermovir (AIC246)

A paradigm shift in HCMV prophylaxis

Read more

Discovery programs

HBV research approaches
HBV research approaches

Achieving cure from HBV infection

Read more
AdV research approaches
AdV research approaches

Adenovirus-specific treatment for ocular infections

Read more
AMR research approaches
AMR research approaches

Combatting rising Anti-microbial resistance (AMR)

Read more

If you or your company are interested in partnering with AiCuris, please contact us.

Contact